eudragit-e has been researched along with theophylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGinity, J; Sauer, D | 1 |
| Farag, Y; Leopold, CS | 1 |
| Alhnan, MA; Gollwitzer, V; Habashy, R; Okwuosa, TC; Soares, C; Timmins, P | 1 |
3 other study(ies) available for eudragit-e and theophylline
| Article | Year |
|---|---|
Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Topics: Acrylic Resins; Algorithms; Biological Availability; Calorimetry, Differential Scanning; Drug Stability; Humidity; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Pharmaceutic Aids; Polyethylene Glycols; Polymethacrylic Acids; Powders; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tablets, Enteric-Coated; Talc; Temperature; Theophylline; Transition Temperature | 2009 |
Development of shellac-coated sustained release pellet formulations.
Topics: Calcium Chloride; Chemistry, Pharmaceutical; Citric Acid; Delayed-Action Preparations; Excipients; Hydrogen-Ion Concentration; Methacrylates; Methylmethacrylates; Resins, Plant; Solubility; Spectroscopy, Fourier Transform Infrared; Theophylline | 2011 |
On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing.
Topics: Capsules; Delayed-Action Preparations; Dipyridamole; Drug Compounding; Drug Liberation; Humans; Polymers; Polymethacrylic Acids; Precision Medicine; Printing, Three-Dimensional; Theophylline | 2018 |